Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 114-122

  Duong, François H T ^a   Dill, Michael T ^a   Matter, Matthias S ^b   Makowska, Zuzanna ^a   Calabrese, Diego ^a   Dietsche, Tanja ^b   Ketterer, Sylvia ^a   Terracciano, Luigi ^b   Heim, Markus H ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DIETHYLNITROSAMINE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P53;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE OVEREXPRESSION; HEPATITIS C VIRUS; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VERY ELDERLY;

ANIMALS; BIOPSY; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; ETOPOSIDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPACIVIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84891358727     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt258     Document Type: Article

References (46)

1. Bosch,F.X. et al. (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127 (5 suppl. 1), S5-S16.
2. McGivern,D.R. et al. (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene, 30, 1969-1983.
3. Moriya,K. et al. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med., 4, 1065-1067.
4. Duong,F.H. et al. (2004) Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology, 126, 263-277.
5. Christen,V. et al. (2007) Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A. Hepatology, 46, 558-565.
6. Millward,T.A. et al. (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci., 24, 186-191.
7. Duong,F.H. et al. (2010) Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology, 51, 741-751.
8. Branzei,D. et al. (2008) Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol., 9, 297-308.
9. Saretzki,G. (2010) Cellular senescence in the development and treatment of cancer. Curr. Pharm. Des., 16, 79-100.
10. Van Hoof,C. et al. (2003) Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim. Biophys. Acta, 1640, 97-104.
11. Okamoto,K. et al. (2002) Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol. Cell, 9, 761-771.
12. Amaral,J.D. et al. (2009) p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. Trends Mol. Med., 15, 531-541.
13. Freed-Pastor,W.A. et al. (2012) Mutant p53: one name, many proteins. Genes Dev., 26, 1268-1286.
14. Mallette,F.A. et al. (2007) The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle, 6, 1831-1836.
15. Chernov,M.V. et al. (2001) Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation. J. Biol. Chem., 276, 31819-31824.
16. Puca,R. et al. (2010) Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene, 29, 4378-4387.
17. Lavin,M.F. et al. (2006) The complexity of p53 stabilization and activation. Cell Death Differ., 13, 941-950.
18. Ichwan,S.J. et al. (2006) Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells. Oncogene, 25, 1216-1224.
19. Li,D.W. et al. (2006) Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene, 25, 3006-3022.
20. Vogelstein,B. et al. (2000) Surfing the p53 network. Nature, 408, 307-310.
21. Vousden,K.H. et al. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol., 8, 275-283.
22. Sherr,C.J. et al. (2002) The RB and p53 pathways in cancer. Cancer Cell, 2, 103-112.
23. Moradpour,D. et al. (1998) Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology, 28, 192-201.
24. Pietschmann,T. et al. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl Acad. Sci. USA, 103, 7408-7413.
25. Blindenbacher,A. et al. (2003) Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology, 124, 1465-1475.
26. Sarasin-Filipowicz,M. et al. (2009) Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol. Cell. Biol., 29, 4841-4851.
27. Thoolen,B. et al. (2010) Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol. Pathol., 38 (suppl. 7), 5S-81S.
28. Chao,E.C. et al. (2006) Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res., 34, 840-852.
29. Jang,J.J. et al. (1992) Progressive atypia in spontaneous and N-nitrosodiethylamine-induced hepatocellular adenomas of C3H/HeNCr mice. Carcinogenesis, 13, 1541-1547.
30. Duong,F.H. et al. (2006) S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro. Hepatology, 43, 796-806.
31. Mumby,M. (2007) PP2A: unveiling a reluctant tumor suppressor. Cell, 130, 21-24.
32. Boudreau,R.T. et al. (2007) Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Cell. Signal., 19, 139-151.
33. Schweyer,S. et al. (2007) Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours. J. Pathol., 213, 72-81.
34. Lim,I.K. (2003) Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680]. Mech. Ageing Dev., 124, 697-708.
35. Mukherjee,B. et al. (2005) Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats. J. Carcinog., 4, 12.
36. Pascale,R.M. et al. (2005) Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology, 42, 1310-1319.
37. Schiffer,E. et al. (2005) Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology, 41, 307-314.
38. Yamamoto,Y. et al. (2004) The orphan nuclear receptor constitutive active/ androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res., 64, 7197-7200.
39. Yoshiji,H. et al. (2004) Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology, 39, 1517-1524.
40. Kalinichenko,V.V. et al. (2004) Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev., 18, 830-850.
41. Saito,S. et al. (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem., 277, 12491-12494.
42. Kao,C.F. et al. (2004) Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene, 23, 2472-2483.
43. Tibbetts,R.S. et al. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev., 13, 152-157.
44. Perfettini,J.L. et al. (2005) Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J. Exp. Med., 201, 279-289.
45. Conkright,M.D. et al. (2005) CREB: the unindicted cancer co-conspirator. Trends Cell Biol., 15, 457-459.
46. Kovach,S.J. et al. (2006) Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma. J. Cell. Physiol., 206, 411-419.